1 |
Jogdeo CM, Panja S, Kanvinde S, Kapoor E, Siddhanta K, Oupický D. Advances in Lipid-Based Codelivery Systems for Cancer and Inflammatory Diseases. Adv Healthc Mater 2023;12:e2202400. [PMID: 36453542 DOI: 10.1002/adhm.202202400] [Reference Citation Analysis]
|
2 |
Chang L, Wu X, Ran K, Tian Y, Ouyang X, Liu H, Gou S, Zhang Y, Ni J. One New Acid-Activated Hybrid Anticancer Peptide by Coupling with a Desirable pH-Sensitive Anionic Partner Peptide. ACS Omega 2023;8:7536-45. [PMID: 36873017 DOI: 10.1021/acsomega.2c06766] [Reference Citation Analysis]
|
3 |
Głowska-Ciemny J, Szymański M, Kuszerska A, Malewski Z, von Kaisenberg C, Kocyłowski R. The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug. Int J Mol Sci 2023;24. [PMID: 36768863 DOI: 10.3390/ijms24032539] [Reference Citation Analysis]
|
4 |
Bennett JA, Hohenhaus A, Andersen TT. Proof-of-Concept Study of an Alpha-Fetoprotein-Derived Peptide for the Management of Canine Mammary Cancer. Animals (Basel) 2023;13. [PMID: 36766292 DOI: 10.3390/ani13030403] [Reference Citation Analysis]
|
5 |
Lai S, Zhang Q, Jin L. Natural and Man-Made Cyclic Peptide-Based Antibiotics. Antibiotics (Basel) 2022;12. [PMID: 36671244 DOI: 10.3390/antibiotics12010042] [Reference Citation Analysis]
|